Howard Edington

Recombinant IL-12 administration induces tumor regression in association with IFN- <i>gamma</i> production.

Chet Nastala, Howard Edington, T G McKinney et al. · The Journal of Immunology · 1994 · 792 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Michael B. Atkins, Michael J. Robertson, Michael S. Gordon et al. · PubMed · 1997 · 590 citations

Medicine, Oncology, Pharmacology +15

Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer.

Kazuhiko Yamasaki, Howard Edington, C McClosky et al. · Journal of Clinical Investigation · 1998 · 438 citations · Full text

Medicine, Molecular Genetics, Molecular Medicine +15

Impaired wound healing and angiogenesis in eNOS-deficient mice

Paul C. Lee, A. Neil Salyapongse, Gwynne A. Bragdon et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1999 · 368 citations

Medicine, Surgery, Tissue Differentiation +16

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

Ahmad A. Tarhini, Howard Edington, Lisa H. Butterfield et al. · PLoS ONE · 2014 · 311 citations · Full text

Medicine, Immunology, Oncology +17